SBUX
48
13
HUM
34
5
FAST
30
2
QCOM
52
4
F
39
3
KEY
33
3
SRE
49
4
HRL
42
-2
GME
65
3
BK
55
-2
D
50
2
AIV
47
-3
NVDA
56
5
PM
56
6
RSG
47
2
AEP
48
-2
ILMN
38
7
STI
46
-4
RHI
44
4
CNX
49
-14
SBUX
48
13
HUM
34
5
FAST
30
2
QCOM
52
4
F
39
3
KEY
33
3
SRE
49
4
HRL
42
-2
GME
65
3
BK
55
-2
D
50
2
AIV
47
-3
NVDA
56
5
PM
56
6
RSG
47
2
AEP
48
-2
ILMN
38
7
STI
46
-4
RHI
44
4
CNX
49
-14
Financhill
Back

VitaSpring Biomedical 10K Form

Sell
8

VSBC
VitaSpring Biomedical

Last Price:
$16.00
Seasonality Move:
-2.51%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive VSBC News And Ratings

See the #1 stock for the next 7 days that we like better than VSBC

VSBC Financial Statistics

Sales & Book Value

Annual Sales: $5.6M
Cash Flow: $0
Price / Cash Flow: 0
Annual Sales: $0.00
Price / Book: 1965.33

Profitability

Net Income (TTM): $0
Gross Margin: $2.1M
Return on Equity: 0%
Return on Assets: 0%

VitaSpring Biomedical Earnings Forecast

Key VitaSpring Biomedical Financial Ratios

  • The Gross Profit Margin over the past 6 years for VSBC is 36.84%.
  • The Selling, General & Administrative Expenses for VSBC have been equal to 10.14% of Gross Profit Margin.
  • The Net Earning history of VSBC is 22.52% of Total Revenues.
  • Per Share Earnings over the last 6 years have been positive in 2 years.

VitaSpring Biomedical Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Current Symbol: VSBC
Website: vitaspringbio.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 2607.56
Forward P/E Ratio: 0

VSBC Technical Analysis vs Fundamental Analysis

Sell
8
VitaSpring Biomedical (VSBC) is a Sell

Is VitaSpring Biomedical a Buy or a Sell?